10 | 10 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
11 | 11 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
2 | 2 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
3 | 3 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
4 | 4 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
5 | 5 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
6 | 6 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
61 | 61 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
7 | 7 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
8 | 8 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
9 | 9 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
About Us | About Us | 02/23/2022 - 04:21 PM | Averix Bio anuncia entrega do registro mestre de medicamentos para seu isolado de... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
About Us | About Us | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Advanced News Search | Advanced News Search | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
All News | All News | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
BELLUS Health Reports Year 2021 Financial Results and Business Highlights | BELLUS Health Reports Year 2021 Financial Results and Business Highlights | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
BELLUS Santé annonce ses résultats financiers et faits saillants pour l’exercice ... | BELLUS Santé annonce ses résultats financiers et faits saillants pour l’exercice ... | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Back ButtonBack | Back ButtonBack | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Become a Member | Become a Member | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Blog | Blog | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Blog | Blog | 02/23/2022 - 04:01 PM | BELLUS Santé annonce ses résultats financiers et faits saillants pour l’exercice ... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Blog | Blog | 02/23/2022 - 06:00 PM | Thermo Fisher Scientific Elects New Director to Board | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Business Wire Events | Business Wire Events | 02/23/2022 - 04:05 PM | Fulgent Genetics Announces Strategic Investment in Spatial Genomics | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Business Wire Events | Business Wire Events | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Business Wire Newsroom | Business Wire Newsroom | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Business Wire Newsroom | Business Wire Newsroom | 02/23/2022 - 04:05 PM | Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
COVID-19 | COVID-19 | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Careers | Careers | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Careers | Careers | 02/23/2022 - 04:05 PM | Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 O... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Chrome | Chrome | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Clear Filters | Clear Filters | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Contact Us | Contact Us | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Contact Us | Contact Us | 02/23/2022 - 04:05 PM | AbCellera to Participate Virtually in the Truist Securities AI Symposium – Biotec... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Cookies Details | Cookies Details | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Deutschland | Deutschland | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Disclosure Resources | Disclosure Resources | 02/23/2022 - 04:22 PM | Vedanta Biosciences to Present at Chardan’s 2022 Metagenomics and Microbiome Medi... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Distribution & Media | Distribution & Media | 02/23/2022 - 05:30 PM | Thermo Fisher Scientific Increases Quarterly Dividend | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Distribution & Media | Distribution & Media | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Edge | Edge | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Education | Education | 02/23/2022 - 07:35 PM | Veristat nomme Joe Scott au poste de directeur financier | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Education | Education | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Filter Icon | Filter Icon | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Find Your News Online | Find Your News Online | 02/23/2022 - 04:30 PM | Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Resu... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Find Your News Online | Find Your News Online | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Firefox | Firefox | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
France | France | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
GlycoMimetics Appoints Bruce Johnson Senior Vice President and Chief Commercial O... | GlycoMimetics Appoints Bruce Johnson Senior Vice President and Chief Commercial O... | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Hong Kong | Hong Kong | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Italy | Italy | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Japan | Japan | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Log In | Log In | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Manage Cookies | Manage Cookies | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Media & Journalist Tools | Media & Journalist Tools | 02/23/2022 - 04:30 PM | ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Hea... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Media & Journalist Tools | Media & Journalist Tools | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
More information | More information | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
News | News | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
News by Industry | News by Industry | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
News by Language | News by Language | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
News by Subject | News by Subject | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
News with Multimedia | News with Multimedia | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Next » | Next » | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Overview | Overview | 02/23/2022 - 04:06 PM | Hims & Hers Health, Inc. to Participate at Citi’s 2022 Virtual Healthcare Confere... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Overview | Overview | 02/23/2022 - 06:01 PM | Alvotech and Fuji Pharma Expand Partnership for Additional Biosimilar Candidate i... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Overview | Overview | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Racial Equality | Racial Equality | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Require Opt-Out | Require Opt-Out | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Safari | Safari | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Sample Press Release | Sample Press Release | 02/23/2022 - 04:30 PM | GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Sample Press Release | Sample Press Release | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Search All | Search All | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Search News | Search News | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Search Site | Search Site | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Services | Services | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Services | Services | 02/23/2022 - 09:42 PM | Exscientia将参加即将在3月召开的投资者会议 | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Sign Up | Sign Up | 02/23/2022 - 04:05 PM | VBI Vaccines Announces PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] Recommende... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Sign Up | Sign Up | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Submit a Press Release | Submit a Press Release | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Submit a Press Release | Submit a Press Release | 02/24/2022 - 01:30 AM | Lysogene Provides Update on Efficacy, Safety and Timelines of the AAVance Phase 2... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Terms of Use | Terms of Use | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Tradeshownews.com | Tradeshownews.com | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Tradeshows & Events | Tradeshows & Events | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Tradeshows & Events | Tradeshows & Events | 02/23/2022 - 09:42 PM | Resumen: Exscientia participará en próximos congresos de inversores en marzo | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
UK Tax Strategy | UK Tax Strategy | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
UK/Ireland | UK/Ireland | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
UK/Ireland | UK/Ireland | 02/23/2022 - 04:00 PM | GlycoMimetics Appoints Bruce Johnson Senior Vice President and Chief Commercial O... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
| | 02/24/2022 - 01:35 AM | Valbiotis publie son calendrier financier 2022 | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
View Privacy Notice | View Privacy Notice | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
| | 02/23/2022 - 04:01 PM | Xencor Reports Fourth Quarter and Full Year 2021 Financial Results | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
© 2022 Business Wire | © 2022 Business Wire | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
| | 02/24/2022 - 01:35 AM | Valbiotis Presents Its 2022 Financial Communication Calendar | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Home | Home | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
| | 02/23/2022 - 04:01 PM | BELLUS Health Reports Year 2021 Financial Results and Business Highlights | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
| | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Become a Member | Become a Member | 02/23/2022 - 04:05 PM | Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and... | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Disclosure Resources | Disclosure Resources | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |
Privacy Statement | Privacy Statement | | | | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | https://www.businesswire.com/portal/site/home/news/industry/?vnsId=31070 | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC | 2022-02-24 06:54:46 UTC |